Condition: Atrial Fibrillation · Cardiomyopathy, Hypertrophic · Radiofrequency Ablation · Sponsor: China National Center for Cardiovascular Diseases
The goal of this clinical trial is to compare the rhythm control effect in hypertrophic non-obstructive patients with non-paroxysmal atrial fibrillation by either concomitant catheter endocardial and thoracoscopic epicardial ablation or catheter ablation alone. The study aims to see if concomitant hybrid ablation can more effectively achieve rhythm control effect than catheter ablation alone in non-paroxysmal atrial fibrillation patients with hypertrophic cardiomyopathy.
This description comes directly from the study's public registry record.
Zhe Zheng, MD.PhD · +86-010-88396051 · zhengzhe@fuwai.com
Yajie Tang, MD.PhD · +8618813019554 · tangyajietangyajie@126.com
Always discuss trial participation with your own doctor first.
| Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05610215